Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Zoetis Analyst Ratings and Price Targets | NYSE:ZTS | Benzinga
Zoetis Inc has a consensus price target of $213.5 based on the ratings of 14 analysts. The high is $244 issued by Barclays on February 14, 2025. The low is $180 issued by Stifel on January 7, 2025. The 3 most-recent analyst ratings were released by Piper Sandler, Barclays, and Morgan Stanley on February 27, 2025, February 14, 2025, and February 14, 2025, respectively. With an average price target of $229 between Piper Sandler, Barclays, and Morgan Stanley, there's an implied 41.67% upside for Zoetis Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Barclays
Morgan Stanley
Stifel
UBS
1calculated from analyst ratings
Analyst Ratings for Zoetis
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/27/2025 | Buy Now | 26.83% | Piper Sandler | David Westenberg60% | $200 → $205 | Maintains | Overweight | Get Alert |
| 02/14/2025 | Buy Now | 50.95% | Barclays | Balaji Prasad53% | $242 → $244 | Maintains | Overweight | Get Alert |
| 02/14/2025 | Buy Now | 47.24% | Morgan Stanley | Erin Wright75% | $243 → $238 | Maintains | Overweight | Get Alert |
| 02/10/2025 | Buy Now | 23.73% | Piper Sandler | David Westenberg60% | $210 → $200 | Maintains | Overweight | Get Alert |
| 01/29/2025 | Buy Now | 50.33% | Morgan Stanley | Erin Wright75% | $248 → $243 | Maintains | Overweight | Get Alert |
| 01/07/2025 | Buy Now | 11.36% | Stifel | Jonathan Block73% | $210 → $180 | Maintains | Buy | Get Alert |
| 12/09/2024 | Buy Now | 21.26% | UBS | — | → $196 | Initiates | → Neutral | Get Alert |
| 12/02/2024 | Buy Now | 33.01% | Leerink Partners | Daniel Clark15% | → $215 | Initiates | → Outperform | Get Alert |
| 10/11/2024 | Buy Now | 42.29% | JP Morgan | Chris Schott60% | $225 → $230 | Maintains | Overweight | Get Alert |
| 09/18/2024 | Buy Now | 29.92% | Stifel | Jonathan Block73% | $200 → $210 | Maintains | Buy | Get Alert |
| 08/27/2024 | Buy Now | 23.73% | Stifel | Jonathan Block73% | $200 → $200 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | 29.92% | Piper Sandler | David Westenberg60% | $195 → $210 | Maintains | Overweight | Get Alert |
| 08/12/2024 | Buy Now | 39.2% | BTIG | Mark Massaro72% | $220 → $225 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | 49.72% | Barclays | Balaji Prasad53% | $230 → $242 | Maintains | Overweight | Get Alert |
| 08/05/2024 | Buy Now | 23.73% | Stifel | Jonathan Block73% | $180 → $200 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | 36.1% | BTIG | Mark Massaro72% | → $220 | Initiates | → Buy | Get Alert |
| 05/08/2024 | Buy Now | 39.2% | HSBC | Morten Herholdt40% | $230 → $225 | Maintains | Buy | Get Alert |
| 05/06/2024 | Buy Now | 21.26% | Goldman Sachs | Nathan Rich43% | $223 → $196 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | 11.36% | Stifel | Jonathan Block73% | $195 → $180 | Maintains | Buy | Get Alert |
| 04/23/2024 | Buy Now | 42.29% | Barclays | Balaji Prasad53% | $260 → $230 | Maintains | Overweight | Get Alert |
| 04/16/2024 | Buy Now | 20.64% | Piper Sandler | David Westenberg60% | $220 → $195 | Reiterates | Overweight → Overweight | Get Alert |
| 04/02/2024 | Buy Now | 20.64% | Stifel | Jonathan Block73% | $215 → $195 | Maintains | Buy | Get Alert |
| 02/20/2024 | Buy Now | 36.1% | Piper Sandler | David Westenberg60% | $215 → $220 | Maintains | Overweight | Get Alert |
| 02/14/2024 | Buy Now | 60.85% | Barclays | Balaji Prasad53% | $255 → $260 | Maintains | Overweight | Get Alert |
| 01/17/2024 | Buy Now | 39.82% | Goldman Sachs | Nathan Rich43% | $190 → $226 | Maintains | Buy | Get Alert |
| 12/19/2023 | Buy Now | 42.29% | Jefferies | Glen Santangelo50% | → $230 | Assumes | → Buy | Get Alert |
| 11/06/2023 | Buy Now | 33.01% | Piper Sandler | David Westenberg60% | $210 → $215 | Maintains | Overweight | Get Alert |
| 10/30/2023 | Buy Now | 20.64% | Stifel | Jonathan Block73% | $205 → $195 | Maintains | Buy | Get Alert |
| 09/12/2023 | Buy Now | 26.83% | Stifel | Jonathan Block73% | → $205 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2023 | Buy Now | 42.29% | HSBC | Morten Herholdt40% | → $230 | Initiates | → Buy | Get Alert |
| 08/28/2023 | Buy Now | 26.83% | Stifel | Jonathan Block73% | $195 → $205 | Maintains | Buy | Get Alert |
| 08/14/2023 | Buy Now | 36.1% | Piper Sandler | David Westenberg60% | $210 → $220 | Maintains | Overweight | Get Alert |
| 08/10/2023 | Buy Now | 31.77% | Goldman Sachs | Nathan Rich43% | $204 → $213 | Maintains | Buy | Get Alert |
| 06/14/2023 | Buy Now | 39.2% | Atlantic Equities | Steve Chesney56% | → $225 | Reiterates | Overweight → Overweight | Get Alert |
| 05/26/2023 | Buy Now | 39.2% | Atlantic Equities | Steve Chesney56% | → $225 | Reiterates | Overweight → Overweight | Get Alert |
| 05/08/2023 | Buy Now | 29.92% | Piper Sandler | David Westenberg60% | $220 → $210 | Maintains | Overweight | Get Alert |
| 02/21/2023 | Buy Now | 60.85% | Barclays | Balaji Prasad53% | $250 → $260 | Maintains | Overweight | Get Alert |
| 11/15/2022 | Buy Now | 53.43% | Morgan Stanley | Erin Wright75% | $264 → $248 | Maintains | Overweight | Get Alert |
| 11/04/2022 | Buy Now | 11.36% | B of A Securities | Michael Ryskin46% | $225 → $180 | Maintains | Buy | Get Alert |
| 11/04/2022 | Buy Now | 11.36% | Goldman Sachs | Nathan Rich43% | $207 → $180 | Maintains | Buy | Get Alert |
| 10/17/2022 | Buy Now | 39.2% | JP Morgan | Chris Schott60% | $250 → $225 | Maintains | Overweight | Get Alert |
| 07/21/2022 | Buy Now | 24.97% | Goldman Sachs | Nathan Rich43% | $208 → $202 | Maintains | Buy | Get Alert |
| 07/12/2022 | Buy Now | 26.83% | Piper Sandler | David Westenberg60% | → $205 | Initiates | → Overweight | Get Alert |
| 06/29/2022 | Buy Now | 39.2% | Stifel | Jonathan Block73% | $225 → $225 | Maintains | Buy | Get Alert |
| 06/24/2022 | Buy Now | 39.2% | Stifel | Jonathan Block73% | $275 → $225 | Maintains | Buy | Get Alert |
| 06/17/2022 | Buy Now | 23.73% | Argus Research | Jasper Hellweg70% | $225 → $200 | Maintains | Buy | Get Alert |
| 05/19/2022 | Buy Now | 28.68% | Goldman Sachs | Nathan Rich43% | $237 → $208 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Zoetis (ZTS) stock?
The latest price target for Zoetis (NYSE:ZTS) was reported by Piper Sandler on February 27, 2025. The analyst firm set a price target for $205.00 expecting ZTS to rise to within 12 months (a possible 26.83% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Zoetis (ZTS)?
The latest analyst rating for Zoetis (NYSE:ZTS) was provided by Piper Sandler, and Zoetis maintained their overweight rating.
When was the last upgrade for Zoetis (ZTS)?
There is no last upgrade for Zoetis
When was the last downgrade for Zoetis (ZTS)?
There is no last downgrade for Zoetis.
When is the next analyst rating going to be posted or updated for Zoetis (ZTS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zoetis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zoetis was filed on February 27, 2025 so you should expect the next rating to be made available sometime around February 27, 2026.
Is the Analyst Rating Zoetis (ZTS) correct?
While ratings are subjective and will change, the latest Zoetis (ZTS) rating was a maintained with a price target of $200.00 to $205.00. The current price Zoetis (ZTS) is trading at is $161.64, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.